Items where Author is "Taki, Elahe"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 5.

Shirani, Maryam and Shariati, Saeedeh and Bazdar, Monireh and Sojoudi Ghamnak, Faezeh and Moradi, Melika and Shams Khozani, Reyhane and Taki, Elahe and Arabsorkhi, Zahra and Heidary9, Mohsen and Bahrami Eskandari, Dorsa (2024) The immunopathogenesis of Helicobacter pylori-induced gastric cancer: a narrative review. Frontiers in Microbiology.

Taki, Elahe and Ghanavati, Roya and Navidifar, Tahereh and Dashtbin, Shirin and Heidary, Mohsen and Moghadamnia, Marjan (2023) Ebanga™: The most recent FDA-approved drug for treating Ebola. Frontiers in Pharmacology.

Taki, Elahe and Soleimani, Faezeh and Asadi, Arezoo and Ghahramanpour, Hossein and Namvar, Ali and Heidary, Mohsen (2022) Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV. Expert Review of Anti-infective Therapy.

Khoshnood, Saeed and Goudarzi, Mehdi and Taki, Elahe and Darbandi, Atieh and Kouhsari, Ebrahim and Heidary, Mohsen and Motahar, Moloudsadat and Moradi, Melika and Bazyar, Hadi (2021) Bedaquiline: Current status and future perspectives. Journal of Global Antimicrobial Resistance.

Khoshnood, Saeed and Goudarzi, Mehdi and Taki, Elahe and Darbandi, Atieh and Kouhsari, Ebrahim and Heidary, Mohsen and sadatMotahar, Moloud and Moradi, Melika and Bazyar, Hadi (2021) Bedaquiline: Current status and future perspectives. Journal of Global Antimicrobial Resistance.

This list was generated on Mon Sep 14 10:54:42 2026 +0430.
Medsab is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.